HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy

We report the case of a 45-year-old patient diagnosed, after four years from the initial diagnosis of infiltrating ductal carcinoma, with lymph node, hepatic, pulmonary and bone diseases deriving from HER2-positive breast cancer. While the association docetaxel + trastuzumab led to a partial respon...

Full description

Bibliographic Details
Main Author: Chiara Saggia
Format: Article
Language:English
Published: AboutScience Srl 2018-06-01
Series:AboutOpen
Subjects:
Online Access:https://journals.aboutscience.eu/index.php/aboutopen/article/view/160